BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34971397)

  • 1. PNC2 (SLC25A36) Deficiency Associated With the Hyperinsulinism/Hyperammonemia Syndrome.
    Shahroor MA; Lasorsa FM; Porcelli V; Dweikat I; Di Noia MA; Gur M; Agostino G; Shaag A; Rinaldi T; Gasparre G; Guerra F; Castegna A; Todisco S; Abu-Libdeh B; Elpeleg O; Palmieri L
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1346-1356. PubMed ID: 34971397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinsulinism/hyperammonemia syndrome caused by biallelic SLC25A36 mutation.
    Safran A; Proskorovski-Ohayon R; Eskin-Schwartz M; Yogev Y; Drabkin M; Eremenko E; Aharoni S; Freund O; Jean MM; Agam N; Hadar N; Loewenthal N; Staretz-Chacham O; Birk OS
    J Inherit Metab Dis; 2023 Jul; 46(4):744-755. PubMed ID: 36695547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase.
    MacMullen C; Fang J; Hsu BY; Kelly A; de Lonlay-Debeney P; Saudubray JM; Ganguly A; Smith TJ; Stanley CA;
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1782-7. PubMed ID: 11297618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.
    Grimaldi M; Karaca M; Latini L; Brioudes E; Schalch T; Maechler P
    Hum Mol Genet; 2017 Sep; 26(18):3453-3465. PubMed ID: 28911206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperinsulinism/hyperammonemia syndrome.
    Palladino AA; Stanley CA
    Rev Endocr Metab Disord; 2010 Sep; 11(3):171-8. PubMed ID: 20936362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital Hyperinsulinemic Hypoglycemia and Hyperammonemia due to Pathogenic Variants in GLUD1.
    Roy K; Satapathy AK; Houhton JAL; Flanagan SE; Radha V; Mohan V; Sharma R; Jain V
    Indian J Pediatr; 2019 Nov; 86(11):1051-1053. PubMed ID: 31119523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase.
    Luczkowska K; Stekelenburg C; Sloan-Béna F; Ranza E; Gastaldi G; Schwitzgebel V; Maechler P
    Hum Genomics; 2020 Mar; 14(1):9. PubMed ID: 32143698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations.
    Kapoor RR; Flanagan SE; Fulton P; Chakrapani A; Chadefaux B; Ben-Omran T; Banerjee I; Shield JP; Ellard S; Hussain K
    Eur J Endocrinol; 2009 Nov; 161(5):731-5. PubMed ID: 19690084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene.
    Tran C; Konstantopoulou V; Mecjia M; Perlman K; Mercimek-Mahmutoglu S; Kronick JB
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):873-6. PubMed ID: 25781533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome.
    Boodhansingh KE; Rosenfeld E; Lord K; Adzick NS; Bhatti T; Ganguly A; De Leon DD; Stanley CA
    Horm Res Paediatr; 2022; 95(5):492-498. PubMed ID: 35952631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial GTP insensitivity contributes to hypoglycemia in hyperinsulinemia hyperammonemia by inhibiting glucagon release.
    Kibbey RG; Choi CS; Lee HY; Cabrera O; Pongratz RL; Zhao X; Birkenfeld AL; Li C; Berggren PO; Stanley C; Shulman GI
    Diabetes; 2014 Dec; 63(12):4218-29. PubMed ID: 25024374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism.
    Stanley CA
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S45-51. PubMed ID: 15050973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene.
    Corrêa-Giannella ML; Freire DS; Cavaleiro AM; Fortes MA; Giorgi RR; Pereira MA
    Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):485-9. PubMed ID: 23295286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome.
    Santer R; Kinner M; Passarge M; Superti-Furga A; Mayatepek E; Meissner T; Schneppenheim R; Schaub J
    Hum Genet; 2001 Jan; 108(1):66-71. PubMed ID: 11214910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators.
    Stanley CA; Fang J; Kutyna K; Hsu BY; Ming JE; Glaser B; Poncz M
    Diabetes; 2000 Apr; 49(4):667-73. PubMed ID: 10871207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients.
    De Lonlay P; Benelli C; Fouque F; Ganguly A; Aral B; Dionisi-Vici C; Touati G; Heinrichs C; Rabier D; Kamoun P; Robert JJ; Stanley C; Saudubray JM
    Pediatr Res; 2001 Sep; 50(3):353-7. PubMed ID: 11518822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two unrelated Chinese patients with hyperinsulinism /hyperammonemia (HI/HA) syndrome due to mutations in glutamate dehydrogenase gene.
    Diao C; Chen S; Xiao X; Wang T; Sun X; Wang O; Song H; Zhang Y; Yu M; Zhang Q; Wang H
    J Pediatr Endocrinol Metab; 2010 Jul; 23(7):733-8. PubMed ID: 20857847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene.
    Stanley CA; Lieu YK; Hsu BY; Burlina AB; Greenberg CR; Hopwood NJ; Perlman K; Rich BH; Zammarchi E; Poncz M
    N Engl J Med; 1998 May; 338(19):1352-7. PubMed ID: 9571255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature.
    Ninković D; Sarnavka V; Bašnec A; Ćuk M; Ramadža DP; Fumić K; Kušec V; Santer R; Barić I
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1083-8. PubMed ID: 27383869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical evaluation of an infant with hypoglycemia resulting from a novel de novo mutation of the GLUD1 gene and hyperinsulinism-hyperammonemia syndrome.
    Balasubramaniam S; Kapoor R; Yeow JH; Lim PG; Flanagan S; Ellard S; Hussain K
    J Pediatr Endocrinol Metab; 2011; 24(7-8):573-7. PubMed ID: 21932603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.